Authors


Tia Wheatley DNP, RN, AOCNS, BMTCN

Latest:

Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT Care

Tia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.


Elizabeth Boateng, MSN, RN, FNP-BC, OCN

Latest:

Caring for an Immunocompromised Bone Marrow Transplant Recipient

Special protocols are required to ensure the safety of patients undergoing bone marrow transplants.


Mike Hennessy Jr

Latest:

The Importance of Quality of Life in Bladder Cancer

In the April 2024 issue of Oncology Nursing News, stories focus on bladder-preserving treatment options in bladder cancer, recent FDA approvals, conference news, and embracing vicarious resilience.


Devon Womack

Latest:

Empower Your Clinical Staff to Meet the Growing Patient Volume

Oncology practices can create more access to care by leveraging the use of APPs, empowering nurses to practice at the top of their licensure, utilizing nurse navigators, and planning ahead.


Todd Shryock

Latest:

Older Patients Are Comfortable With Telehealth and Prefer It as an Option

92% of those over 70 say they are comfortable with telehealth.


Christine Cooper, RN, BSN

Latest:

Key Takeaways for Patients With Myelofibrosis

Patients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.


Heather Niccum Haag, BSN, RN, CCRN

Latest:

Heather Niccum Haag on Improving Patient Education With Belzutifan

Heather Niccum Haag, BSN, RN, CCRN, shares her experience creating an educational resource for her patients with Von-Hippel Lindau tumors who are receiving belzutifan.


Jason Astrin, DMSc, MBA, PA-C, DFAAPA

Latest:

Advanced Practice Providers Are Uniquely Suited for Survivorship Care

Advanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.


Ashley Chan

Latest:

Idecabtagene Vicleucel Approved by FDA in R/R Multiple Myeloma

The FDA has approved idecabtagene vicleucel for patients with relapsed/refractory multiple myeloma who have received 2 prior lines of therapy.


Antonia DePace

Latest:

Global Study Suggests More Informational Resources Needed for Renal Cell Carcinoma

A global study revealed that patients and caregivers alike reported insufficient knowledge surrounding renal cell carcinoma.


Nicole McEntee, BSN, RN, OCN, BMTCN

Latest:

Caring for a Patient Undergoing CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma

The introduction of CAR T-cell therapy for patients with relapsed/refractory multiple myeloma is considered one of the most significant advancements in the past decade.


Jason Kiernan, PhD, RN, ACNP

Latest:

Prescribing 20 mg of Mozart for Chemotherapy-Induced Nausea

A Michigan State University investigator is preparing to expand on an encouraging pilot study that used a music-listening intervention to influence chemotherapy-induced nausea.


Heather Simonsen, MA

Latest:

5 Media Tips and Tricks For Health Care Professionals

Heather Simonsen, MA, outlines some ways for health care professionals to feel more comfortable in the spotlight.


Amanda Warner, MS, BSN, RN, OCN

Latest:

Oncology Drug Crash Course: Teclistamab-cqyv (Tecvayli)

Amanda Warner, MS, BSN, RN, OCN, who is manager of research informatics & real world evidence with Florida Cancer Specialists & Research Institute, provides an in-depth look at teclistamab in a downloadable fact sheet.



Ian E. Krop, MD, PhD

Latest:

Datopotamab Deruxtecan Demonstrates Manageable Safety Profile in TNBC

Compared with other antibody-drug conjugates, datopotamab deruxtecan was associated with lower rates of neutropenia, pneumonitis, and hematologic toxicity.


Dawn Landolph, RN, BSN, OCN, MPA

Latest:

Rx Road Map: Adagrasib (Krazati)

Dawn Landolph, RN, BSN, OCN, MPA, provides an in-depth look at adagrasib for the treatment of patients with KRAS G12C-mutated, locally advanced or metastatic non-small cell lung cancer in a downloadable reference sheet.


Mary Hanley, LMSW

Latest:

Talking With Patients About Potential Cancer Misinformation

Oncology nurses can help their patients navigate misinformation that they may find online.


Image of Serenity Mirabito
Serenity Mirabito, MSN, RN, OCN

Latest:

Top Executives Vow to Improve Health Disparities among Patients with Multiple Myeloma

Oncology nurses are often the main point of contact for newly diagnosed patients with cancer. We have the opportunity to ensure that each person starts their journey with equality and equity on their side.


Miranda Lankas

Latest:

Chemotherapy Plus Endocrine Therapy Increases Cognitive Impairment in Breast Cancer

Patients with breast cancer may be at risk for more intense cognitive impairment following treatment with chemotherapy plus endocrine therapy.


Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS

Latest:

Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing Radiation

Hilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.


Dana-Farber Cancer Institute

Latest:

Study suggests Lymphoma Patients With Depression or Anxiety Experience Shorter Survival Times

Patients with depression had a 37% higher risk of dying from their disease than patients without a mental health diagnosis.


Karmanos Cancer Institute

Latest:

Karmanos nurse wins MDONS Outstanding Oncology Nurse of the Year Award

Agnes Pilecki, BSN, RN, a nurse on Barbara Ann Karmanos Cancer Institute’s bone marrow transplant unit, has been named the Metro Detroit Oncology Nursing Society’s (MDONS) Outstanding Oncology Nurse of the Year.


Michelle Fortier, PhD

Latest:

Approach Health Disparities From All Angles

April is National Minority Health Month, highlighting the need for health care and community sectors to come together and improve cancer outcomes for underserved populations.


Reanne Booker, MN, NP

Latest:

Reanne Booker on Factors to Consider When Discussing Palliative Radiation

Reanne Booker, MN, NP, highlights factors that make a patient a good candidate for palliative radiation.


Jessica Scruton, BSN, RN, CCM

Latest:

Care Management Tools Can Mitigate Clinician Burnout

Although technology alone can’t solve clinician burnout, it can provide the means for organizations to provide better care while increasing efficiency and alleviating stress.


Paula Anastasia, RN, MN, AOCN

Latest:

Paula Anastasia on PARP Inhibitor Ineligibility Factors for Women With Ovarian Cancer

Paula Anastasia, RN, MN, AOCN, highlights circumstances in which patients may not be eligible to receive benefit with a PARP inhibitor.


Morgan Bayer

Latest:

Ruxolitinib Plus Belumosudil Confers a 55% Response Rate in GVHD

Patients with GVHD treated with ruxolitinib plus belumosudil experienced an overall response rate of 55%, which may suggest an interaction between inflammatory pathways.


Cheryl VerStrate, DNP, AGPCNP-BC, OCN

Latest:

Cheryl VerStrate on the Pitfalls of Direct-to-Consumer Genetic Tests

Cheryl VerStrate, DNP, AGPCNP-BC, OCN, discusses why nurses should be prepared to discuss direct-to-consumer genomic testing with their patients.


Ashling Wahner

Latest:

Estrogen Therapy May Impact Ovarian/Endometrial Cancer Incidence in Postmenopausal Women After Hysterectomy

Postmenopausal women who had undergone hysterectomy and received treatment with conjugated equine estrogen alone had an increased incidence of ovarian cancer and mortality rates.

© 2024 MJH Life Sciences

All rights reserved.